#United States #San Mateo #Medical Devices #Cala Health #TAPS Therapy

Cala Health: A Beacon of Innovation in HealthTech

Cala Health, a leader in the field of bioelectronic medicine, has recently earned a prestigious spot on the TIME and Statista's World's Top HealthTech Companies for 2026 list within the Medical Devices & Wearables category. This recognition underscores the company's commitment to transforming healthcare through innovative solutions, particularly with its flagship product, Cala TAPS®.

What Sets Cala Apart?

The Cala TAPS® therapy is pivotal in the management of essential tremors, providing a cutting-edge solution for millions who struggle with tremors related to conditions like Parkinson’s disease. This wearable device, designed to be worn on the wrist, has gained attention for being one of the most researched treatments in the wearable health technology sector.

The advancements don’t stop here. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared the next-generation product, the Cala kIQ® Plus system. This new system builds on its predecessor’s technology, introducing new therapeutic modes and adaptive calibration designed to enhance the effectiveness of tremor relief and offer personalized treatment plans tailored to individual patient needs.

Cala Health's CEO, Deanna Harshbarger, pointed out the significance of this innovation, stating, "Over 7 million Americans are affected by essential tremor, which significantly impacts their daily lives. Our wearable technology aims to alleviate these challenges and improve quality of life."

Understanding the Recognition

The TIME World's Top HealthTech Companies List evaluates over 500 companies across more than 30 countries. The selection process includes a deep dive into financial performance, reputation, and engagement metrics. Criteria such as revenue, employee count, media coverage, and web traffic over the last two years are meticulously considered. Being ranked among this elite group is not just an accolade but an affirmation of the impact Cala Health has made in the healthcare technology space.

A Commitment to Patient Care

Cala Health stands out not only for its innovations but also for its dedication to patient-centered care. The Cala kIQ® system is notable for being the only FDA-cleared wearable device that offers effective treatment for hand tremors due to essential tremor and Parkinson’s disease. Its unique transcutaneous afferent patterned stimulation (TAPS™) therapy offers a non-invasive approach to managing tremors, making it a game changer for individuals seeking relief.

Moreover, the Cala® system is available at no cost to eligible Veterans Affairs (VA) beneficiaries, and it is also covered by Medicare for those who meet the necessary criteria. Cala Health remains proactive, advocating for broader coverage options under Medicare Advantage and commercial payer plans, ensuring that more patients gain access to this life-improving technology.

The Future of Cala Health

With its recent accolades and ongoing developments, Cala Health is set on a path to further innovation and expansion. As the healthcare landscape continues to evolve with technology integration, Cala is leading the charge in enhancing patient outcomes through personalized, innovative solutions. The company’s steadfast commitment to improving the lives of individuals living with tremors embodies the spirit of health technology innovation.

In conclusion, Cala Health's recognition as a leading HealthTech company in 2026 is more than just a title; it signifies a dedication to merging healthcare with technology, making strides toward ensuring that revolutionary treatments are accessible and effective for those who need them most.